Lilli Priesterroth, Germany
Johannes Gutenberg University Mainz Institute of Psychology, Health PsychologyPresenter of 1 Presentation
USE OF ADVANCED DIABETES TECHNOLOGIES IN PEOPLE WITH TYPE 1 DIABETES AND DYSFUNCTIONAL OR DISTURBED EATING
Abstract
Background and Aims
People with type 1 diabetes show an increased risk for dysfunctional eating behaviors and comorbid eating disorders. In this population, the use of continuous subcutaneous insulin infusion (CSII), continuous glucose monitoring (CGM) or automated insulin delivery systems (AID) may come with benefits, but also specific pitfalls. In this systematic review, we aimed to (1) identify and describe research investigating the use of advanced diabetes technologies (DT) in people with type 1 diabetes and dysfunctional/disordered eating and (2) to discuss potential advantages and disadvantages of DT use in this population, derived from previous research.
Methods
A systematic literature search was conducted in two databases for English language articles published between 2000 and 2020 (Prospero ID: CRD42020160244).
Results
From 70 publications initially identified, 17 met the inclusion criteria. Overall, evidence on potential benefits and pitfalls of DT use in people with type 1 diabetes and dysfunctional/disordered eating is scarce. Providing the greatest self-management flexibility, CSII may have beneficial effects on dysfunctional/disordered eating but may also facilitate manipulation of insulin dosage. CGM data may complement the diagnostic process of dysfunctional/disordered with a physiological indicator of insulin omission (i.e., time spent in hyperglycemia).
Conclusions
Evidence on potential (dis)advantages of DT use is scarce and mostly stems from cross-sectional data, small pilot trials in samples that predominantly consist of female adolescents/young adults, and anecdotical results from case reports. Prospective data from larger samples are needed to reliably determine the potential effects of DT on dysfunctional/disordered eating.